Zacks Investment Research cut shares of Abcam PLC (NASDAQ:ABCZY) from a hold rating to a sell rating in a research note issued to investors on Friday morning.

According to Zacks, “Abcam PLC distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam PLC is headquartered in Cambridge, the United Kingdom. “

Shares of Abcam PLC (NASDAQ:ABCZY) opened at 13.90 on Friday. The company’s 50-day moving average is $12.91 and its 200 day moving average is $11.65. Abcam PLC has a 1-year low of $9.13 and a 1-year high of $13.95. The firm has a market capitalization of $2.81 billion and a price-to-earnings ratio of 53.88.

TRADEMARK VIOLATION WARNING: “Abcam PLC (NASDAQ:ABCZY) Downgraded by Zacks Investment Research” was originally reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright law. The correct version of this piece can be viewed at

Get a free copy of the Zacks research report on Abcam PLC (ABCZY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Abcam PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.